USA - NASDAQ:ERAS - US29479A1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ERAS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-16 | Stifel | Initiate | Buy |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-08-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Raymond James | Initiate | Outperform |
| 2025-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-11-18 | Jefferies | Initiate | Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | Capital One | Initiate | Overweight |
| 2024-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-11-29 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-11 | HC Wainwright & Co. | Initiate | Buy |
| 2023-06-06 | Mizuho | Maintains | Buy -> Buy |
| 2023-06-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-03-30 | Mizuho | Initiate | Buy |
| 2023-02-24 | Goldman Sachs | Initiate | Buy |
| 2023-02-03 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
14 analysts have analysed ERAS and the average price target is 4.76 USD. This implies a price increase of 104.73% is expected in the next year compared to the current price of 2.325.
The consensus rating for ERASCA INC (ERAS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.